1
0
0
News
Netzwerk-Profile
LinkedIn: Dieter Moosmayer | LinkedIn
Dieter Moosmayers berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Dieter Moosmayer ...
LinkedIn: Dieter Moosmayer | LinkedIn
Sehen Sie sich das berufliche Profil von Dieter Moosmayer (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- ...
کتاب های نویسنده Dieter Moosmayer | کتابکو - Ketabkooketabkoo.com › book › author › dieter-moosmayer
ketabkoo.com
Antibody Engineering. Nina Strebe, Frank Breitling, Dieter Moosmayer, Bodo Brocks, Stefan Dübel (auth.), Roland Kontermann, Stefan Dübel (eds.) ,
Author Search Results - E-Library - Stipramelibrary.stipram.ac.id › Author › Home
elibrary.stipram.ac.id
Andreas Wilmen, Dongli Wang, Xinquan Wang, Maxine Bauzon, Ji-Yun Kim, Lars Linden, Liang Li, Ursula Egner, Tobias Marquardt, Dieter Moosmayer, Jan Tebbe ...
Business-Profile
patentbuddy: Dieter Moosmayer
WAJANT, HARLAD, Berlin, DE
Besitz
US (morpholin-4-yl)-1,7-naphthyridines
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
Bücher
Dieter Heldmann | Bayer | 2 Publications | 16 CitationsTypeset
typeset.io
... Alexander Walter 1, Reinhard Nubbemeyer 1, Dieter Heldmann 1, Lothar Sobek 1, Federica Morandi, Anna K. Schrey, Dieter Moosmayer 1, Judith Günther 1, ... › authors
Antibody Engineering | E-bok | Ellibs E-bokhandel
www.ellibs.com
Ellibs E-bokhandel - E-bok: Antibody Engineering - Författare: Kontermann, Roland - Pris: 219,95€
Nina Strebe | VDOC.PUB
vdoc.pub
Nina Strebe, Frank Breitling, Dieter Moosmayer, Bodo Brocks, Stefan Dübel (auth.), Roland Kontermann, Stefan Dübel (eds.) 17,607; 2,294. Preview Document ... › author › nina-str...
Antibody Engineering - Seite Google Books-Ergebnisseite
books.google.com
Expression of scFw in L-Form Bacteria DIETER MOOSMAYER and JöRG F. RIPPMANN Introduction The production of heterologous protein, including recombinant ...
Dokumente zum Namen
(11) EE Aepa.ee
www1.epa.ee
Dieter Moosmayer. , Berlin, DE. Matthias Grell. , Darmstadt, DE. Peter Scheurich. , Stuttgart, DE.
Expression and Characterization of the Reverse Transcriptase ...febs.onlinelibrary.wiley.com › doi › abs › j
febs.onlinelibrary.wiley.com
Dieter Moosmayer. Department for Virology and Immunology, German Primate Centre, Göttingen, Germany. Search for more papers by this author.
Antibody Engineering [PDF] [4g7r1f3l04k0]VDOC.PUB
vdoc.pub
3 Nina Strebe, Frank Breitling, Dieter Moosmayer, Bodo Brocks, and Stefan Du¨bel 2. Coning Hybridoma cDNA by RACE .
Luteinizing Hormone Receptor Antagonist BAY-899Bayer
www.bayer.com
Dieter Moosmayer. Judith Günther. Martina Schäfer. Katrin Nowak-Reppel. Hilmar Weinmann. Heiner Fritzemeier†. Page Thank You. Page › file › download
Wissenschaftliche Veröffentlichungen
Characterization of the endogenous reverse transcriptase reaction...
www.sciencedirect.com
Wolfgang Liike, Brigitte Dirks, Dieter Moosmayer, Klaus Dieter Jentsch and Gerhard Hunsmann. Deutsches Prirnatenzentrum, Abteilung virologie und ...
Vol. 116, No. 7, February 12, of Proceedings of the JSTORwww.jstor.org › stable
www.jstor.org
Roman C. Hillig, Brice Sautier, Jens Schroeder, Dieter Moosmayer, André Hilpmann, Christian M. Stegmanna, Nicolas D. Werbeck, Hans Briem, Ulf Boemer, ...
Species-Crossreactive scFv Against the Tumor Stroma Marker ...molmed.biomedcentral.com › articles
molmed.biomedcentral.com
· Dieter Moosmayer. Present address: Schering AGBerlin, Germany. Bodo ... Bodo Brocks, Eva Behrle, Klaus Pfizenmaier & Dieter Moosmayer.
Aktivierung nicht-apoptotischer Signalwege durch TRAIL ...Universität Stuttgart
elib.uni-stuttgart.de
von F Mühlenbeck · — Scheurich, Dieter Moosmayer, Jürg Tschopp and Harald Wajant. TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and ...
Veröffentlichungen allgemein
Publications Authored by Dieter Moosmayer | PubFacts
www.pubfacts.com
Publications Authored by Dieter Moosmayer
Antibody Engineering | SpringerLink
link.springer.com
Interest in recombinant antibody technologies has rapidly increased because of the wide range of possible applications in therapy and diagnosis, especially in...
(PDF) The Novel ATR Inhibitor BAY Is Efficacious asresearch.amanote.com › publication › the-novel-atr-...
research.amanote.com
Dieter Moosmayer Uwe Eberspächer Sven Golfier Christoph A. Schatz Simon J. Baumgart Bernard Haendler Pascale Lejeune Andreas Schlicker Franz von Nussbaum ...
Publications Authored by Ursula Egner | PubFacts
www.pubfacts.com
Publications Authored by Ursula Egner
Artikel & Meinungen
Targeted inhibition of activated protein C by a non-active-site...
www.nature.com
Ursula Egner, Tobias Marquardt & Dieter Moosmayer. Biological Development, Bayer, Berkeley, CAUSA. Ashley Hesslein.
Sonstiges
Dieter Moosmayer | LinkedIn
www.linkedin.com
View Dieter Moosmayer's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Dieter Moosmayer ...
Human and humanized fap-alpha-specific antibodies - Google Patentspatents.google.com › patent
patents.google.com
Other languages: French; Inventor: John-Edward Park: Pilar Garin-Chesa: Klaus Pfizenmaier: Dieter Moosmayer: Michael Mersmann: Alexej Schmidt ...
Konjugati, ki obsegajo protitelo, specifično za domeno ED-B ...patents.google.com › patent
patents.google.com
Dieter Moosmayer: Giovanni Neri. Worldwide applications DK. Application number: DK T. Filing date: Legal status: PT. Application ...
Site-specific antibody-mediated activation of proapoptotic cytokineswww.google.com › patents
www.google.com
Dieter Moosmayer: Thomas Wuest; Current Assignee. The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation ...
Dieter Moosmayer | CiNii Researchcir.nii.ac.jp › crid
cir.nii.ac.jp
Dieter Moosmayer · この人物について · 関連論文 · 関連研究データ · 関連図書・雑誌 · 関連博士論文 · 関連プロジェクト · 関連その他成果物 · 詳細情報.
ones and 2,5,6,7-tetrahydro-3h-pyrrolo[2,1-c][1,2,4]triazol Google
patents.google.com
... Timmermann: Dmitry Zubov: Carsten TERJUNG: Niels Lindner: Volker BADOCK: Dieter Moosmayer: Hideki MIYATAKE ONDOZABAL: Steven Moore: Alexander Schulz ...
Z-Library single sign on
1lib.domains
Z-Library single sign on | Z-Library. Download books for free. Find books
Dieter Moosmayer
www.infona.pl
Search results for: Dieter Moosmayer ... Dieter Moosmayer · Immunotechnology > > 3 > 4 > Objective: The guided selection ...
Glioblastoma: Moosmayer, Dieter - Expertscape.com
www.expertscape.com
Dieter Moosmayer has special expertise in Glioblastoma
搜索页_+Dieter+Moosmayercglhub.com
www.cglhub.com
作者：Wolfgang Lueke ; Klaus Hoefer ; Dieter Moosmayer ; Peter Nickel ; Gerhard Hunsmann ; and Klaus Dieter Jentsch. 刊名：Biochemistry. 出版年：
jnm.snmjournals.org › contentFIGURE 4. | Imaging of Tumor Angiogenesis Using 99mTc-Labeled ...
jnm.snmjournals.org
Dietmar Berndorff, Sandra Borkowski, Dieter Moosmayer, Francesca Viti, Beate Müller-Tiemann, Stephanie Sieger, Matthias Friebe, Christoph S. Hilger, ...
2-(morfolin-4-il)-1,7-naftiridini - Podaci o izabranom patentuit-app.dziv.hr › Pretrage › Detaljno.aspx
it-app.dziv.hr
Dieter MoosmayerBerlin, DE. 3. Knut EisBerlin, DE. 4. Franz von NussbaumBerlin, DE ...
A minimal mathematical model for the initial molecular interactions ...www.aimsciences.org › doi › mbe
www.aimsciences.org
Frank Mühlenbeck, Pascal Schneider, Jean-Luc Bodmer, Ralph Schwenzer, Angelika Hauser, Gisela Schubert, Peter Scheurich, Dieter Moosmayer, Jürg Tschopp and ...
A TNF receptor antagonistic scFv, which is not secreted in Infona.plwww.infona.pl › resource
www.infona.pl
... Dieter Moosmayer · Details · Contributors · Fields of science · Bibliography · Quotations · Similar · Collections. Source. Immunotechnology > > 3 > 3 >
An Overview on Small Molecule Inhibitors of BRD4 - Read by ...
read.qxmd.com
Marie Jung, Martin Philpott, Susanne Müller, Jessica Schulze, Volker Badock, Uwe Eberspächer, Dieter Moosmayer, Benjamin Bader, Norbert Schmees, ... › read › an-...
Bayer Aktiengesellschaft Utility application Patents List | Page 8capedge.com › patent › companyId › typeAndEntityType › page
capedge.com
... Dieter MOOSMAYER. Filed: 14 May 20 · Utility. Acyl Sulfonamides for Treating Cancer. 21 Jul 22. Léa Aurelie Bouché, Daniel Korr, Antonius ter Laak, Ernesto ...
A minimal mathematical model for the initial molecular interactions...
www.aimsciences.org
Harald Wajant, Dieter Moosmayer, Thomas Wüest, Till Bartke, Elke Gerlach, Ulrike Schönherr, Nathalie Peters, Peter Scheurich and Klaus Pfizenmaier, ...
Verwandte Suchanfragen zu Dieter Moosmayer
| Elke Gerlach Judith Günther Harald Wajant | Frank Breitling Laura Furst Jens Schroeder | Ulrike Schönherr Marius Glück Brice Sautier |
Personen Vorname "Dieter" (45661) Name "Moosmayer" (54) |
sortiert nach Relevanz / Datum